Burleson Tess 4
4 · Salarius Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Burleson Tess
Director
Transactions
- Award
Common Stock
2023-01-03+1,440→ 2,722 total
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024